跳至主要内容
临床试验/NCT05585944
NCT05585944尚未招募不适用

" Effect of Single-nucleotide Polymorphism of CD40 Gene rs1883832 C/T on the Risk of Immune Thrombocytopenic Purpura "

Sohag University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2022年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
80
试验地点
1
主要终点
rs1883832C/T related single-nucleotide polymorphism

研究概览

简要总结

Immune thrombocytopenia is an acquired autoimmune disease, in which platelets are opsonized by auto-antibodies and destroyed by phagocytic cells .Genetic polymorphisms in the immune mediators have been suggested to play a pivotal role in the pathogenesis of many autoimmune disorders . Several genetic polymorphisms of the immune system genes have been described in ITP such as interleukins, tumor necrosis factors (TNF) alpha and beta, and interferon-gamma., These polymorphisms were found to be associated with an increased risk of ITP progression or exacerbation .CD40 is a co-stimulatory 4348 kDa glycoprotein molecule composed of 277 amino acid residues which belongs to the tumor necrosis family. It is encoded by a gene which is located at chromosome 20q11-13, expressed mainly on antigen presenting cells (APCs), some non-immune cells and tumors.Antinuclear antibodies (ANA) is a collective term for a large and heterogeneous group of circulating autoantibody. Reflecting their clinical importance, ANA are diagnostic, prognostic or classification criteria for many autoimmune diseases.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
1 Year 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • sign an informed written consent from the patients or their parents
  • patient with newly diagnosed ITP
  • patient age > 1 year and < 65 years and both sexes are included.

排除标准

  • Refusal to sign an informed written consent
  • patient with persistent ITP, patient with secondary immune thrombocytopenia
  • patient age < 1 year or > 65 years.

结局指标

主要结局

rs1883832C/T related single-nucleotide polymorphism

时间窗: 6 months

effect of single-nucleotide polymorphism of CD40 gene (rs1883832 C/T) on the risk of immune thrombocytopenic purpura

次要结局

  • ANA(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nagwa Mohamed Aboelmahasen

assisstant lecturer of clinical and chemical pathology department, Sohag university hospital

Sohag University

研究点 (1)

Loading locations...

相似试验